Your browser doesn't support javascript.
loading
Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities.
Beavers, Suzanne F; Pascopella, Lisa; Davidow, Amy L; Mangan, Joan M; Hirsch-Moverman, Yael R; Golub, Jonathan E; Blumberg, Henry M; Webb, Risa M; Royce, Rachel A; Buskin, Susan E; Leonard, Michael K; Weinfurter, Paul C; Belknap, Robert W; Hughes, Stephen E; Warkentin, Jon V; Welbel, Sharon F; Miller, Thaddeus L; Kundipati, Saini R; Lauzardo, Michael; Barry, Pennan M; Katz, Dolly J; Garrett, Denise O; Graviss, Edward A; Flood, Jennifer M.
Afiliação
  • Beavers SF; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Pascopella L; California Department of Public Health, Tuberculosis Control Branch, Richmond, California.
  • Davidow AL; Department of Biostatistics, Rutgers School of Public Health, Newark, New Jersey.
  • Mangan JM; University of Florida, Southeastern National Tuberculosis Center, Gainesville, Florida.
  • Hirsch-Moverman YR; Charles P. Felton National Tuberculosis Center, ICAP, Mailman School of Public Health, Columbia University, New York, New York.
  • Golub JE; Johns Hopkins University, Center for Tuberculosis Research, Baltimore, Maryland.
  • Blumberg HM; Division of Infectious Diseases, Department of Medicine.
  • Webb RM; Division of Infectious Disease, University of Mississippi Medical Center, Mississippi State Department of Health, Jackson, Mississippi.
  • Royce RA; Research Triangle International, Research Triangle Park, North Carolina.
  • Buskin SE; Public Health Seattle and King County, Seattle, Washington.
  • Leonard MK; Emory University School of Medicine, Atlanta, Georgia.
  • Weinfurter PC; Westat, Inc., Rockville, Maryland.
  • Belknap RW; Denver Public Health and Hospital Authority, Denver, Colorado.
  • Hughes SE; Bureau of Tuberculosis Control, New York State Health Department, Albany, New York.
  • Warkentin JV; Tennessee Department of Health, Tuberculosis Elimination Program, Nashville, Tennessee.
  • Welbel SF; Rush Medical College, Rush University Medical Center, Chicago, Illinois.
  • Miller TL; Department of Health Management and Policy, University of North Texas Health Science Center School of Public Health, Fort Worth, Texas.
  • Kundipati SR; Respiratory Health Association of Metropolitan Chicago, Chicago, Illinois; and.
  • Lauzardo M; University of Florida, Southeastern National Tuberculosis Center, Gainesville, Florida.
  • Barry PM; California Department of Public Health, Tuberculosis Control Branch, Richmond, California.
  • Katz DJ; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Garrett DO; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Graviss EA; Department of Pathology, Houston Methodist Research Institute, Houston, Texas.
  • Flood JM; California Department of Public Health, Tuberculosis Control Branch, Richmond, California.
Ann Am Thorac Soc ; 15(6): 683-692, 2018 06.
Article em En | MEDLINE | ID: mdl-29490150
ABSTRACT
Rationale More information on risk factors for death from tuberculosis in the United States could help reduce the tuberculosis mortality rate, which has remained steady for more than a decade.

Objective:

To identify risk factors for tuberculosis-related death in adults.

Methods:

We performed a retrospective study of 1,304 adults with tuberculosis who died before treatment completion and 1,039 frequency-matched control subjects who completed tuberculosis treatment in 2005 to 2006 in 13 states reporting 65% of U.S. tuberculosis cases. We used in-depth record abstractions and a standard algorithm to classify deaths in persons with tuberculosis as tuberculosis-related or not. We then compared these classifications to causes of death as coded in death certificates. We used multivariable logistic regression to calculate adjusted odds ratios for predictors of tuberculosis-related death among adults compared with those who completed tuberculosis treatment.

Results:

Of 1,304 adult deaths, 942 (72%) were tuberculosis related, 272 (21%) were not, and 90 (7%) could not be classified. Of 847 tuberculosis-related deaths with death certificates available, 378 (45%) did not list tuberculosis as a cause of death. Adjusting for known risks, we identified new risks for tuberculosis-related death during treatment absence of pyrazinamide in the initial regimen (adjusted odds ratio, 3.4; 95% confidence interval, 1.9-6.0); immunosuppressive medications (adjusted odds ratio, 2.5; 95% confidence interval, 1.1-5.6); incomplete tuberculosis diagnostic evaluation (adjusted odds ratio, 2.2; 95% confidence interval, 1.5-3.3), and an alternative nontuberculosis diagnosis before tuberculosis diagnosis (adjusted odds ratio, 1.6; 95% confidence interval, 1.2-2.2).

Conclusions:

Most persons who died with tuberculosis had a tuberculosis-related death. Intensive record review revealed tuberculosis as a cause of death more often than did death certificate diagnoses. New tools, such as a tuberculosis mortality risk score based on our study findings, may identify patients with tuberculosis for in-hospital interventions to prevent death.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Ann Am Thorac Soc Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Geórgia

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Ann Am Thorac Soc Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Geórgia